2-cyclopropyl-4-fluorobenzoic acid | 959992-79-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-cyclopropyl-4-fluorobenzoic acid
• CAS: 959992-79-1
• 化学式: C₁₀H₉FO₂
• 分子量: 180.179
• InChiKey: ILZHOPCOIVKLDI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  methyl 4-fluoro-2-iodobenzoate 在 四(三苯基膦)钯 、 potassium trimethylsilonate 作用下， 以 四氢呋喃 为溶剂， 反应 4.0h， 生成 2-cyclopropyl-4-fluorobenzoic acid
  参考文献：
  名称：

  [EN] BRIDGED DIAZEPANE OREXIN RECEPTOR ANTAGONISTS
  [FR] COMPOSÉS DE DIAZÉPANE PONTÉS UTILES EN TANT QU'ANTAGONISTES DES RÉCEPTEURS D'OREXINE

  摘要：

  本发明涉及桥联二氮杂环庚烷化合物，其为俄雷欣受体拮抗剂。本发明还涉及所述化合物在潜在的治疗或预防涉及俄雷欣受体的神经和精神障碍和疾病中的用途。本发明还涉及包含这些化合物的组合物。本发明还涉及这些组合物在潜在的预防或治疗涉及俄雷欣受体的疾病中的用途。

  公开号：

  WO2016085783A1

文献信息

• [EN] METHYL DIAZEPANE OREXIN RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DE RÉCEPTEUR D'OREXINE DE TYPE MÉTHYL-DIAZÉPANE
  申请人：MERCK SHARP & DOHME

  公开号：WO2016085784A1

  公开（公告）日：2016-06-02

  The present invention is directed to methyl diazepane compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.

  本发明涉及甲基二氮杂环己烷化合物，其为促进睡眠的受体拮抗剂。本发明还涉及所述化合物在潜在的治疗或预防涉及促进睡眠的神经和精神障碍和疾病中的用途。本发明还涉及包含这些化合物的组合物。本发明还涉及这些组合物在潜在的预防或治疗涉及促进睡眠的疾病中的用途。
• [EN] DIAZEPANE OREXIN RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DE RÉCEPTEUR D'OREXINE À BASE DE DIAZÉPANE
  申请人：MERCK SHARP & DOHME

  公开号：WO2015095111A1

  公开（公告）日：2015-06-25

  The present invention is directed to diazepane compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the diazepane compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

  本发明涉及二氮杂环庚烷化合物，其为促进睡眠的受体拮抗剂。本发明还涉及所述二氮杂环庚烷化合物在潜在治疗或预防涉及促进睡眠的神经和精神障碍和疾病中的用途。本发明还涉及包含这些化合物的药物组合物。本发明还涉及这些药物组合物在预防或治疗涉及促进睡眠的疾病中的用途。
• Methyl diazepane orexin receptor antagonists
  申请人：MERCK SHARP & DOHME CORP.

  公开号：US10000499B2

  公开（公告）日：2018-06-19

  The present invention is directed to methyl diazepane compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.

  本发明涉及甲基二氮杂环庚烷化合物，它是奥曲肽受体的拮抗剂。本发明还涉及本文所述化合物在潜在治疗或预防涉及奥曲肽受体的神经和精神疾病中的用途。本发明还涉及包含这些化合物的组合物。本发明还涉及这些组合物在潜在预防或治疗涉及奥曲肽受体的此类疾病中的用途。
• DIAZEPANE OREXIN RECEPTOR ANTAGONISTS
  申请人：KUDUK SCOTT D.

  公开号：US20160318923A1

  公开（公告）日：2016-11-03

  The present invention is directed to diazepane compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the diazepane compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
• METHYL DIAZEPANE OREXIN RECEPTOR ANTAGONISTS
  申请人：KUDUK SCOTT D.

  公开号：US20170305916A1

  公开（公告）日：2017-10-26

  The present invention is directed to methyl diazepane compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.